Free Trial

Bios Capital Management, Lp Top Holdings and 13F Report (2026)

About Bios Capital Management, Lp

Investment Activity

  • Bios Capital Management, Lp has $52.87 million in total holdings as of March 31, 2026.
  • Bios Capital Management, Lp owns shares of 6 different stocks, but just 2 companies or ETFs make up 80% of its holdings.
  • Approximately 0.72% of the portfolio was purchased this quarter.
  • About 0.62% of the portfolio was sold this quarter.
  • This quarter, Bios Capital Management, Lp has purchased 6 new stocks and bought additional shares in 1 stock.
  • Bios Capital Management, Lp sold shares of 2 stocks and completely divested from 0 stocks this quarter.

Largest Holdings

ACTUATE THERAPEUTICS INC
$27,536,989
OPUS GENETICS INC
$16,759,602
REIN THERAPEUTICS INC
$2,577,088
Lantern Pharma
$1,184,276

Largest Purchases this Quarter

REIN THERAPEUTICS INC
291,624 shares (about $379.11K)

Largest Sales this Quarter

Lantern Pharma
145,072 shares (about $198.75K)
IN8BIO INC
85,612 shares (about $126.71K)

Sector Allocation Over Time

Map of 500 Largest Holdings ofBios Capital Management, Lp

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
ACTUATE THERAPEUTICS INC
$27,536,9890.0%10,049,99652.1%COM
OPUS GENETICS INC
$16,759,6020.0%3,683,42931.7%COM
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
$4,560,0000.0%6,000,0008.6%Medical
REIN THERAPEUTICS INC
$2,577,088$379,111 â–²17.2%1,982,3754.9%COM NEW
Lantern Pharma Inc. stock logo
LTRN
Lantern Pharma
$1,184,276$198,749 â–¼-14.4%864,4352.2%Medical
IN8BIO INC
$248,351$126,706 â–¼-33.8%167,8050.5%COM NEW

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data